Cancer and its treatments lead to financial toxicity for patients, according to cancer specialists who reported the findings from using the Comprehensive Score for Financial Toxicity (COST) questionnaire in Cancer.
New findings presented by the Cancer Support Community suggest that a significant proportion of patients have difficulty conceptualizing value in terms of current cost-benefit models used by policymakers.
An analytic tool that allocates clinical care costs and quality measures to individual patient encounters may help to enhance the quality of care delivered by physicians, according to research published in JAMA.
Vinblastine monotherapy has few side effects and equivalent survival to other therapies when used to treat pediatric low-grade glioma, according to a recent study.
A cost-effective analysis found that the addition of elective neck dissection to primary surgery in patients with oral cavity cancer showed a cost reduction and improved health outcomes, reported researchers from the University of California, San Diego.